IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VALSECCHI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.583
EU - Europa 1.883
AS - Asia 875
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
AF - Africa 8
SA - Sud America 5
Totale 6.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.562
CN - Cina 603
PL - Polonia 472
UA - Ucraina 408
IT - Italia 261
DE - Germania 259
GB - Regno Unito 125
FI - Finlandia 121
HK - Hong Kong 96
IE - Irlanda 72
SG - Singapore 71
FR - Francia 64
IN - India 54
RU - Federazione Russa 25
BE - Belgio 22
VN - Vietnam 20
CZ - Repubblica Ceca 19
CA - Canada 18
SE - Svezia 12
IR - Iran 8
AU - Australia 7
HU - Ungheria 7
A1 - Anonimo 5
MA - Marocco 5
NL - Olanda 5
SA - Arabia Saudita 5
EU - Europa 4
PK - Pakistan 4
AT - Austria 3
ID - Indonesia 3
JP - Giappone 3
MU - Mauritius 3
TR - Turchia 3
CH - Svizzera 2
ES - Italia 2
HN - Honduras 2
NZ - Nuova Zelanda 2
PE - Perù 2
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MX - Messico 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.372
Salva come PNG Salva come JPEG
Città #
Fairfield 487
Warsaw 471
Woodbridge 370
Jacksonville 314
Ashburn 291
Ann Arbor 258
Houston 235
Chandler 230
Seattle 179
Wilmington 177
Cambridge 167
New York 137
Princeton 137
Nanjing 97
Hong Kong 96
Beijing 91
Helsinki 91
Dearborn 80
Dublin 72
Brescia 66
Shenyang 47
Jinan 44
Nanchang 44
Boardman 36
Des Moines 36
Hebei 34
Lancaster 34
Singapore 34
Changsha 33
Tianjin 33
Milan 32
Jiaxing 23
Los Angeles 22
Dong Ket 20
Shanghai 20
Ningbo 17
San Diego 17
Zhengzhou 17
Brussels 16
Brno 15
Lanzhou 14
Haikou 13
London 12
Norwalk 12
Washington 12
San Francisco 11
Taizhou 11
Toronto 11
Hangzhou 9
Orange 9
Guangzhou 8
Munich 8
San Mateo 8
Kunming 7
Leawood 7
Manchester 7
Rome 7
Taiyuan 7
Trieste 7
Fuzhou 6
Gent 6
Hefei 6
Tehran 6
Mantova 5
Nürnberg 5
Tulsa 5
Bergamo 4
Olomouc 4
Ottawa 4
Pune 4
Rabat 4
Turin 4
Verona 4
Augusta 3
Bolzano 3
Changchun 3
Cologno Monzese 3
Columbia 3
Iesi 3
Jeddah 3
Kilburn 3
Phoenix 3
Redwood City 3
Sydney 3
Vienna 3
Amsterdam 2
Bordighera 2
Budapest 2
Castelli Calepio 2
Chengdu 2
Chicago 2
Chiswick 2
Esslingen am Neckar 2
Flero 2
Gravina in Puglia 2
Hounslow 2
Lima 2
Madrid 2
Malnate 2
Montichiari 2
Totale 4.933
Salva come PNG Salva come JPEG
Nome #
New Copy Number Variations in Schizophrenia 260
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 257
Farmacoterapia antipsicotica e disturbi cognitivi. 192
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 165
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. 135
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 134
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 130
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 130
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 127
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 124
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 122
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 120
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 114
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 113
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 113
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 112
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 109
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 108
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 108
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 106
The role of the cytochine network in schizophrenia: an overview. 106
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 105
Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. 104
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 103
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 102
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 101
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia 100
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. 99
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review 97
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 97
Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy. 96
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 95
Analysis of Copy Number Variations in Schizophrenia Italian Patients 91
A multimodal imaging study of never-medicated adults with schizophrenia 89
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 88
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 88
New Copy Number Variations in Schizophrenia Italian Patients 86
Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. 86
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 86
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 85
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 84
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder 83
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 83
Mitochondrial DNA haplogroups and age at onset of schizophrenia 82
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. 80
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 79
Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia. 77
Detection of high level of autozygosity in a group of Italian schizophrenia patients 76
Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia. 76
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 75
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 73
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 67
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 67
Cerebrovascular accidents in elderly people treated with antipsychotic drugs. A systematic review 65
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 60
Implementing cognitive rehabilitation interventions for schizophrenia patients in mental health services: Focus on Integrated Psychological Therapy (IPT) 58
Manuale di clinica e riabilitazione psichiatrica. Dalle conoscenze teoriche alla pratica dei servizi di salute mentale. Vol. 2: Riabilitazione psichiatrica 58
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 58
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 56
Panic disorder with and without comorbidity: data on epidemiology, course and treatment outcome. 54
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 54
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 53
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 51
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 49
THE FACTOR STRUCTURE FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN PHARMACOGENETICS: 102T/C 5-HT2A POLYMORPHISM AND RESPONSE TO RISPERIDONE 48
Esperienze di switch a cariprazina in pazienti affetti da schizofrenia con ricorrenze 48
La comorbidità per uso di sostanze nei disturbi psicotici e nella schizofrenia. 44
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 43
Paliperidone palmitate in short- and long-term treatment of schizophrenia 33
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 30
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 23
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 3
Totale 6.573
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.646 0 0 62 163 117 230 191 203 160 203 216 101
2020/20211.126 33 118 31 114 69 94 75 117 141 139 136 59
2021/2022577 45 105 15 32 7 23 27 33 28 58 56 148
2022/2023639 86 9 6 68 46 176 4 67 96 11 40 30
2023/2024777 41 14 70 82 46 196 31 21 119 29 18 110
2024/202549 19 30 0 0 0 0 0 0 0 0 0 0
Totale 6.573